HCMT
EPRS

Highland Capital Management (Texas)’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Highland Capital Management (Texas)’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-190,033
Closed -$512K – 315
2016
Q1 		$512K Sell
190,033
-248,243
-57% -$697K 0.02% 178
2015
Q4 		$1.35M Buy
+438,276
New +$1.98M 0.04% 178

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Highland Capital Management (Texas)'s EPRS Position: Q2 2016 in Review

Highland Capital Management (Texas) sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q2 2016, closing a stake of 190,033 shares — an estimated $512K sold.

Highland Capital Management (Texas) first reported a position in EPRS in Q4 2015 and held it in 2 quarters. The position peaked at $1.35M in Q4 2015. 32 funds tracked by Wall St. Rank hold EPRS as of Q2 2016.

  • Highland Capital Management (Texas) reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 190,033 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q2 2016, an estimated $512K.
  • Highland Capital Management (Texas) first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1.35M in Q4 2015.
  • 32 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q2 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2016, filed 15 Aug 2016.